Mold Illness Symptoms: How to Tell If Mold Is Making You Sick

Mold illness, also called Chronic Inflammatory Response Syndrome (CIRS), announces itself through a cluster of symptoms across several organ systems at once rather than one dominant complaint, most often brain fog, profound fatigue, sinus congestion, joint pain, and gut upset that track with time spent in a specific building. An estimated 25 percent of people carry HLA-DR gene variants that impair the immune system’s ability to clear biotoxins, which is why two people sharing the same water-damaged space can end up with very different health outcomes (Mudarri and Fisk, 2007).

What Is Mold Illness?

Mold illness, formally known as Chronic Inflammatory Response Syndrome (CIRS), is a multi-system inflammatory condition triggered by exposure to water-damaged buildings. It’s not an allergy and it’s not an infection. It’s an innate immune response that gets stuck in an activated state because the body cannot properly clear biotoxins [1].

The biotoxins involved include mycotoxins (produced by mold species like Stachybotrys, Aspergillus, and Penicillium), bacterial endotoxins, beta-glucans, and volatile organic compounds (VOCs) released in water-damaged environments. When a genetically susceptible person inhales or ingests these compounds, their immune system launches an inflammatory cascade that it cannot turn off through normal pathways.

An estimated 50% of buildings in the US have water damage, and roughly 25% of the population carries HLA-DR gene variants that impair biotoxin clearance. When these two factors overlap, chronic illness can develop [2].

CIRS is also called biotoxin illness or water-damaged building (WDB) related illness, terms used interchangeably in the clinical literature. Dr. Ritchie Shoemaker, an internal medicine physician, developed much of the diagnostic framework referenced throughout this piece, including the biomarker panel and the visual contrast sensitivity screen described below. Functional and environmental medicine clinicians who manage CIRS often coordinate with allergists, immunologists, and industrial hygienists, since the condition sits at the intersection of environmental exposure and immune dysregulation. Most CIRS-specific testing and treatment protocols fall outside standard FDA approved diagnostic pathways: they are used under a clinician’s judgment, and insurance coverage is inconsistent, so patients should expect to pay out of pocket for specialized panels and consultations.

The Symptom Pattern

What makes mold illness difficult to diagnose is that it affects nearly every organ system. Patients don’t present with one chief complaint. They present with 8-15 symptoms across multiple body systems. This multi-system pattern is actually the most important diagnostic clue.

Neurological and Cognitive Symptoms

• Brain fog: Difficulty with word finding, short-term memory, concentration, and executive function. This is the most common complaint and often the most debilitating.
• Headaches: Frequent, often described as a “pressure” headache distinct from migraines or tension headaches
• Light sensitivity: Photophobia, difficulty adjusting between indoor and outdoor light
• Numbness and tingling: Peripheral neuropathy symptoms, particularly in hands and feet
• Vertigo and balance issues: Proprioceptive dysfunction, feeling unsteady
• Tremors: Fine tremor in hands, often noticed during handwriting or holding objects

Fatigue and Pain

• Profound fatigue: Not proportional to exertion. Present upon waking. Worsened by mold re-exposure.
• Muscle aches and cramps: Generalized myalgia without a clear musculoskeletal cause. Often mistaken for fibromyalgia.
• Joint pain without swelling: Arthralgia that moves between joints. Inflammatory markers (CRP, sed rate) are often normal despite significant pain.
• Morning stiffness: Lasting 30-60 minutes, similar to inflammatory arthritis but without joint damage on imaging

Respiratory Symptoms

• Chronic sinus congestion: Not responsive to standard allergy treatments or antibiotics
• Shortness of breath: Often mild but persistent, without clear findings on pulmonary function testing
• Chronic cough: Dry, nonproductive cough that doesn’t resolve
• Recurrent sinus infections: Multiple courses of antibiotics per year with incomplete resolution

GI Symptoms

• Abdominal pain and bloating: Often diagnosed as IBS
• Diarrhea or loose stools: Intermittent, sometimes alternating with constipation
• Appetite changes: Decreased appetite or unusual food intolerances that seem to develop suddenly
• Nausea: Low-grade, persistent

Other Common Symptoms

• Increased urination and thirst: ADH dysregulation is common in CIRS
• Static shocks: Changes in skin charge are reported by many CIRS patients
• Temperature dysregulation: Feeling hot or cold at inappropriate times
• Night sweats: Unrelated to menopause or infection
• Metallic taste: Persistent abnormal taste perception
• Skin sensitivity: Rashes, hives, or dermatographia
• Mood changes: Anxiety, depression, and irritability that onset with exposure

The Diagnostic Challenge

The average CIRS patient sees 7-10 doctors over several years before receiving a correct diagnosis [3]. The symptom spread leads to a series of normal test results and specialist referrals that go nowhere:

• Neurologist for headaches and brain fog: MRI normal
• Rheumatologist for joint pain: Autoimmune markers negative
• Pulmonologist for shortness of breath: PFTs normal
• Gastroenterologist for GI symptoms: Endoscopy normal, diagnosed with IBS
• Psychiatrist: Told symptoms are stress-related or psychosomatic

The key insight: normal results on standard testing in a patient with multi-system symptoms should raise suspicion for CIRS, not dismiss the patient.

Screening and Diagnostic Tests

Visual Contrast Sensitivity (VCS) Test

VCS testing measures the ability to detect differences in contrast between light and dark patterns. Biotoxin exposure impairs the neural pathways that process contrast, making this a sensitive screening tool. VCS testing is 92% sensitive and 80% specific for CIRS when performed correctly [4]. Online VCS tests are available as a first-step screen.

Biomarker Panel

CIRS-trained practitioners use a panel of inflammatory and neuroimmune markers. No single test is diagnostic, but a pattern of abnormalities is highly suggestive:

HLA-DR Genetic Testing

HLA-DR typing identifies genetic susceptibility to biotoxin illness. Specific haplotypes (particularly 4-3-53, 11-3-52B, and 12-3-52B) are associated with impaired ability to present biotoxins to the adaptive immune system for clearance [5]. This is a one-time test. It doesn’t diagnose CIRS, but it explains why you’re susceptible while your housemate living in the same moldy environment is fine.

Environmental Testing

If you suspect your home or workplace, environmental testing confirms the exposure:

• ERMI (Environmental Relative Moldiness Index): DNA-based dust sample analysis. Scores above 2 suggest problematic mold levels.
• HERTSMI-2: A subset of ERMI focusing on the 5 most pathogenic mold species. Scores above 10 warrant remediation.
• Air sampling: Captures airborne spore counts. Useful but limited by timing and location.

Common Misdiagnoses

CIRS is frequently misdiagnosed as:

• Fibromyalgia
• Chronic fatigue syndrome
• Depression/anxiety
• IBS
• Allergies or chronic sinusitis
• Multiple sclerosis (in severe cases with neurological symptoms)
• Lyme disease (significant symptom overlap)

The distinguishing feature is the relationship to environment. If symptoms improve when you leave a specific building and worsen when you return, that’s a strong signal pointing toward mold illness rather than these other conditions.

When to Suspect Mold Illness

Consider mold illness if:

• You have symptoms in 4 or more organ systems simultaneously
• Symptoms started or worsened after moving, water damage, or a flood
• You improve on vacation or when away from your home/office for extended periods
• Standard workups have been negative despite real symptoms
• Multiple family members or coworkers are sick with similar complaints
• You have a known history of water damage in your home or workplace
• Your symptoms are progressive despite treatment for the conditions you’ve been diagnosed with

How Is Mold Illness Treated?

Treatment for CIRS follows a sequence rather than a single intervention. The first and most important step is reducing or eliminating contact with the water-damaged building, since ongoing exposure keeps the inflammatory response active regardless of what else is done. Mold toxicity treatment protocols typically layer binders to interrupt biotoxin recirculation, nutritional support, and a staged return to normal activity once inflammatory markers trend toward baseline.

Some functional and integrative clinics add supportive therapies alongside remediation and binder protocols. Ozone therapy is used by some practitioners for its proposed antimicrobial and immune-modulating effects, though evidence specific to CIRS is limited and the therapy is not an FDA approved treatment for this use. The ozone therapy clinic directory shows which providers offer it alongside standard CIRS care, and a closer look at ozone therapy for mold related illness covers how clinics frame that use. Patients managing broader toxic exposure, including heavy metals alongside mycotoxins, may also want the toxic exposure treatment guide and the toxic mold exposure condition page to understand how clinicians sequence detox focused care. None of these approaches reverses structural damage that has already occurred, and most are cash pay regardless of how they are marketed.

Because remediation and binder therapy alone do not resolve every case, some patients look for clinics that coordinate CIRS specific protocols. On regenerated.com, inclusion in the directory is not an endorsement: listing order is not a paid ranking, Featured slots are labeled and capped, a Verified badge reflects completed credential checks rather than advertising spend, and browsing the directory itself costs patients nothing. Reading a clinic’s profile against the symptom pattern and testing described above is a reasonable way to decide who to call first.

Frequently asked questions

What are the first signs of mold illness?

The earliest signs are usually brain fog, unusual fatigue that does not match exertion, and sinus congestion that does not respond to standard allergy treatment. Many patients also notice pressure-type headaches, joint pain that moves between joints without swelling, and symptoms that ease on vacation and return within days of being back in a specific building. A pattern across several organ systems, not one dominant symptom, is the clue clinicians look for first.

How do you test for mold illness?

There is no single lab test that confirms CIRS. Clinicians typically start with a Visual Contrast Sensitivity screen, add a biomarker panel checking markers like MSH, C4a, TGF-beta 1, and MMP-9, and may order HLA-DR genetic testing to assess susceptibility. Environmental testing, such as ERMI or HERTSMI-2 dust sampling, confirms whether a specific building is the likely source. The diagnosis rests on the combined pattern across these tests plus a multi-system symptom history, not any one result.

Can mold illness cause anxiety and depression?

Yes. Mood changes, including anxiety, irritability, and depressive symptoms, are commonly reported in CIRS and are thought to stem from the same inflammatory cascade that affects the brain and nervous system rather than being a separate psychiatric condition. These mood symptoms often track with exposure, worsening in a water-damaged building and easing away from it. Patients whose mood symptoms follow that pattern may also want to look at biofeedback based approaches for anxiety alongside addressing the exposure itself.

How long does it take to recover from mold illness?

Recovery timelines vary widely and depend on exposure duration, genetic susceptibility, and how quickly the water-damaged environment is addressed. Some patients notice improvement within weeks once exposure stops and a structured protocol begins, while others with longer exposure histories need an extended course of binder therapy and monitoring. The mold toxicity treatment overview walks through the general phases clinicians use, though no fixed timeline applies to every patient.

Is mold illness the same as a mold allergy?

No. A mold allergy is an IgE mediated reaction that causes classic allergy symptoms such as sneezing, itchy eyes, and hives shortly after exposure, and it typically responds to antihistamines. Mold illness, or CIRS, is an innate immune response to biotoxins that does not resolve with antihistamines and instead produces a wider, multi-system pattern, brain fog, joint pain, and gut symptoms, that improves mainly when exposure stops rather than when allergy medication is taken.

Can mold illness cause permanent damage?

Prolonged, unaddressed exposure has been associated with structural brain changes on specialized imaging in some studies, though most symptoms patients report are functional and improve once exposure ends and treatment begins [1]. Evidence on long term, irreversible injury remains limited, and outcomes differ by individual genetics and exposure length. Anyone with ongoing multi-system symptoms after leaving a water-damaged building should pursue a structured medical evaluation rather than assume the damage is permanent.

Related Reading

• Mold Illness and CIRS: The Evidence-Based Guide (Pillar)
• Mold Toxicity Treatment: Binders, Protocols, and Recovery Timeline
• Leaky Gut Symptoms: Signs Your Gut Barrier Is Compromised
• Biofeedback for Anxiety: How It Works and Where to Start

Sources

1. Shoemaker RC, House D, Ryan JC. Structural brain abnormalities in patients with inflammatory illness acquired following exposure to water-damaged buildings: a volumetric MRI study using NeuroQuant. Neurotoxicol Teratol. 2014;45:18-26. doi:10.1016/j.ntt.2014.06.004 ↩
2. Mudarri D, Fisk WJ. Public health and economic impact of dampness and mold. Indoor Air. 2007;17(3):226-235. doi:10.1111/j.1600-0668.2007.00474.x ↩
3. Shoemaker RC, Hudnell HK, House DE, et al. Atovaquone plus cholestyramine in patients seropositive for Babesia microti with chronic fatigue unresponsive to other therapies. Toxicol Ind Health. 2006;22(2):75-84. ↩
4. Shoemaker RC, Hudnell HK. Possible estuary-associated syndrome: symptoms, vision, and treatment. Environ Health Perspect. 2001;109(5):539-545. doi:10.1289/ehp.01109539 ↩
5. Shoemaker RC, Rash J, Simon EK. Sick building syndrome in water-damaged buildings: generalization of the chronic biotoxin-associated illness paradigm to indoor toxigenic fungi. In: Bioaerosols, Fungi, Bacteria, Mycotoxins and Human Health. 2005:52-63. ↩
6. Mendell MJ, Mirer AG, Cheung K, et al. Respiratory and allergic health effects of dampness, mold, and dampness-related agents: a review of the epidemiologic evidence. Environ Health Perspect. 2011;119(6):748-756. doi:10.1289/ehp.1002410
7. WHO. WHO guidelines for indoor air quality: dampness and mould. World Health Organization. 2009. ISBN:978-92-890-4168-3
8. Hope J. A review of the mechanism of injury and treatment approaches for illness resulting from exposure to water-damaged buildings, mold, and mycotoxins. ScientificWorldJournal. 2013;2013:767482. doi:10.1155/2013/767482